We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.6%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$8.89B
AUM Growth
+$1.45B
Cap. Flow
+$1.09B
Cap. Flow %
12.29%
Top 10 Hldgs %
26.12%
Holding
266
New
39
Increased
114
Reduced
52
Closed
27

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$63.8M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$50M
3
VR
Validus Hold Ltd
VR
+$44.1M
4
PBYI icon
Puma Biotechnology
PBYI
+$33.5M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$30.4M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$59.3M
2
DHR icon
Danaher
DHR
+$44.2M
3
HOLX
Hologic
HOLX
+$42M
4
BDX icon
Becton Dickinson
BDX
+$40.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$38.7M

Sector Composition

Rank Sector Weight
1 Financials 21.97%
2 Healthcare 21.33%
3 Technology 19.13%
4 Communication Services 9.13%
5 Industrials 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$695M 7.83%
+2,767,500
New +$682M
META icon
2
Meta Platforms (Facebook)
META
$1.51T
$272M 3.06%
1,590,857
+46,403
+3% +$7.74M
GOOG icon
3
Alphabet (Google) Class C
GOOG
$3.9T
$243M 2.74%
5,076,460
-60,000
-1% -$2.79M
AAPL icon
4
Apple
AAPL
$4.89T
$235M 2.65%
6,105,396
+151,068
+3% +$5.86M
JNJ icon
5
Johnson & Johnson
JNJ
$634B
$171M 1.92%
1,311,752
+180,000
+16% +$23.9M
CB icon
6
Chubb
CB
$140B
$152M 1.71%
1,066,843
+79,482
+8% +$11.5M
MSFT icon
7
Microsoft
MSFT
$2.84T
$152M 1.71%
2,035,148
-10,279
-0.5% -$751K
ELV icon
8
Elevance Health
ELV
$81.9B
$137M 1.54%
721,865
+30,000
+4% +$5.71M
MKL icon
9
Markel Group
MKL
$25B
$133M 1.5%
124,634
+1,250
+1% +$1.29M
BRK.B icon
10
Berkshire Hathaway Class B
BRK.B
$1.07T
$131M 1.47%
714,170
+7,535
+1% +$1.33M
DLB icon
11
Dolby
DLB
$4.72B
$126M 1.42%
2,195,701
+377,234
+21% +$19.8M
ACGL icon
12
Arch Capital
ACGL
$36.1B
$123M 1.38%
3,738,681
+96,240
+3% +$3.1M
VR
13
DELISTED
Validus Hold Ltd
VR
$122M 1.38%
2,483,846
+869,258
+54% +$44.1M
C icon
14
Citigroup
C
$222B
$122M 1.37%
1,670,506
+118,836
+8% +$8.11M
GOOGL icon
15
Alphabet (Google) Class A
GOOGL
$3.91T
$109M 1.22%
2,231,940
-60,000
-3% -$2.85M
AAPL icon
16
CALL
Apple
AAPL
$4.89T
$108M 1.21%
2,800,000
+400,000
+17% +$15.5M
CELG
17
DELISTED
Celgene Corp
CELG
$103M 1.16%
706,541
+26,500
+4% +$3.61M
BABA icon
18
Alibaba
BABA
$269B
$99.6M 1.12%
576,558
-35,721
-6% -$5.79M
V icon
19
Visa
V
$677B
$99.1M 1.12%
941,896
+22,825
+2% +$2.31M
MRSH
20
Marsh
MRSH
$86.3B
$95.8M 1.08%
1,142,778
+33,778
+3% +$2.68M
AMZN icon
21
Amazon
AMZN
$2.5T
$90.9M 1.02%
1,892,840
+84,640
+5% +$4.16M
CNQ icon
22
Canadian Natural Resources
CNQ
$96.9B
$88.2M 0.99%
4,828,421
+262,395
+6% +$4.02M
ABT icon
23
Abbott
ABT
$180B
$84.4M 0.95%
1,580,917
+175,000
+12% +$8.78M
AME icon
24
Ametek
AME
$55.5B
$81.5M 0.92%
1,234,176
-134,186
-10% -$8.48M
AON icon
25
Aon
AON
$77.3B
$80.8M 0.91%
553,202
+13,100
+2% +$1.83M
1
2 3 4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Polar Capital held 266 positions worth $8.89B, up 20% from $7.43B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Polar Capital deployed $1.09B of net new capital in Q3 2017, opening 39 new positions and adding to 114 existing holdings. Its largest new stake was Puma Biotechnology: 360,000 shares worth $43.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Medtronic, an estimated $59.3M trimmed.

  • Polar Capital's largest Q3 2017 buy was Puma Biotechnology: 360,000 shares worth $43.1M.
  • Polar Capital added most to Amgen in Q3 2017, an estimated $63.8M increase.
  • Polar Capital's biggest Q3 2017 reduction was Medtronic, cutting an estimated $59.3M.
  • Polar Capital fully exited Hologic in Q3 2017, selling an estimated $42M.
  • Polar Capital's ten largest holdings make up 26% of its $8.89B portfolio in Q3 2017.
  • Polar Capital opened 39 new positions and closed 27 in Q3 2017.
  • Polar Capital's portfolio value rose 20% quarter-over-quarter to $8.89B.

Based on Polar Capital's 13F filing for Q3 2017, filed 14 Nov 2017.